These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 16859410)

  • 21. Human cytochrome p450 enzymes of importance for the bioactivation of methyleugenol to the proximate carcinogen 1'-hydroxymethyleugenol.
    Jeurissen SM; Bogaards JJ; Boersma MG; ter Horst JP; Awad HM; Fiamegos YC; van Beek TA; Alink GM; Sudhölter EJ; Cnubben NH; Rietjens IM
    Chem Res Toxicol; 2006 Jan; 19(1):111-6. PubMed ID: 16411663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxidation of tienilic acid by human yeast-expressed cytochromes P-450 2C8, 2C9, 2C18 and 2C19. Evidence that this drug is a mechanism-based inhibitor specific for cytochrome P-450 2C9.
    Jean P; Lopez-Garcia P; Dansette P; Mansuy D; Goldstein JL
    Eur J Biochem; 1996 Nov; 241(3):797-804. PubMed ID: 8944768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of arachidonic acid, prostaglandins, retinol, retinoic acid and cholecalciferol on xenobiotic oxidations catalysed by human cytochrome P450 enzymes.
    Yamazaki H; Shimada T
    Xenobiotica; 1999 Mar; 29(3):231-41. PubMed ID: 10219964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of cytochrome P450 inhibition assays for drug discovery using human liver microsomes with LC-MS, rhCYP450 isozymes with fluorescence, and double cocktail with LC-MS.
    Di L; Kerns EH; Li SQ; Carter GT
    Int J Pharm; 2007 Apr; 335(1-2):1-11. PubMed ID: 17137735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of human cytochrome P450 3A4 in the metabolism of DA-8159, a new erectogenic.
    Ji HY; Lee HW; Kim HH; Kim DS; Yoo M; Kim WB; Lee HS
    Xenobiotica; 2004; 34(11-12):973-82. PubMed ID: 15801542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue distribution of mRNA expression of human cytochrome P450 isoforms assessed by high-sensitivity real-time reverse transcription PCR.
    Nishimura M; Yaguti H; Yoshitsugu H; Naito S; Satoh T
    Yakugaku Zasshi; 2003 May; 123(5):369-75. PubMed ID: 12772594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of Luminogenic Substrates as Probe Substrates for Bacterial Cytochrome P450 Enzymes: Application to
    Ortega Ugalde S; Ma D; Cali JJ; Commandeur JNM
    SLAS Discov; 2019 Aug; 24(7):745-754. PubMed ID: 31208248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Highly miniaturized formats for in vitro drug metabolism assays using vivid fluorescent substrates and recombinant human cytochrome P450 enzymes.
    Trubetskoy OV; Gibson JR; Marks BD
    J Biomol Screen; 2005 Feb; 10(1):56-66. PubMed ID: 15695344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and validation of a liquid-chromatography high-resolution tandem mass spectrometry approach for quantification of nine cytochrome P450 (CYP) model substrate metabolites in an in vitro CYP inhibition cocktail.
    Dinger J; Meyer MR; Maurer HH
    Anal Bioanal Chem; 2014 Jul; 406(18):4453-64. PubMed ID: 24830396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of cytochrome P450 enzymes responsible for N -dealkylation of a new oral erectogenic, mirodenafil.
    Lee HS; Park EJ; Ji HY; Kim SY; Im GJ; Lee SM; Jang IJ
    Xenobiotica; 2008 Jan; 38(1):21-33. PubMed ID: 18098061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolites.
    Marill J; Cresteil T; Lanotte M; Chabot GG
    Mol Pharmacol; 2000 Dec; 58(6):1341-8. PubMed ID: 11093772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytochrome P450-mediated herb-drug interaction potential of Galgeun-tang.
    Lee SY; Lee JY; Kang W; Kwon KI; Park SK; Oh SJ; Ma JY; Kim SK
    Food Chem Toxicol; 2013 Jan; 51():343-9. PubMed ID: 23104244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of cytochrome P450 forms involved in the 4-hydroxylation of valsartan, a potent and specific angiotensin II receptor antagonist, in human liver microsomes.
    Nakashima A; Kawashita H; Masuda N; Saxer C; Niina M; Nagae Y; Iwasaki K
    Xenobiotica; 2005 Jun; 35(6):589-602. PubMed ID: 16192110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of cytochrome P450 3A4 and P-glycoprotein by the isoxazolyl-penicillin antibiotic flucloxacillin.
    Huwyler J; Wright MB; Gutmann H; Drewe J
    Curr Drug Metab; 2006 Feb; 7(2):119-26. PubMed ID: 16472102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of In Vitro Cytochrome P450 Inhibition and In Vitro Fate of Structurally Diverse N-Oxide Metabolites: Case Studies with Clozapine, Levofloxacin, Roflumilast, Voriconazole and Zopiclone.
    Giri P; Naidu S; Patel N; Patel H; Srinivas NR
    Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):677-688. PubMed ID: 27853934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of human cytochrome P450 isoforms involved in the 3-hydroxylation of quinine by human live microsomes and nine recombinant human cytochromes P450.
    Zhao XJ; Yokoyama H; Chiba K; Wanwimolruk S; Ishizaki T
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1327-34. PubMed ID: 8968357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of human cytochrome P450 enzymes by licochalcone A, a naturally occurring constituent of licorice.
    He W; Wu JJ; Ning J; Hou J; Xin H; He YQ; Ge GB; Xu W
    Toxicol In Vitro; 2015 Oct; 29(7):1569-76. PubMed ID: 26100226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fully automated analysis of activities catalysed by the major human liver cytochrome P450 (CYP) enzymes: assessment of human CYP inhibition potential.
    Moody GC; Griffin SJ; Mather AN; McGinnity DF; Riley RJ
    Xenobiotica; 1999 Jan; 29(1):53-75. PubMed ID: 10078840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Automated luminescence-based cytochrome P450 profiling using a simple, elegant robotic platform.
    Larson B; Banks P; Cali JJ; Sobol M; Shultz S
    J Lab Autom; 2011 Feb; 16(1):47-55. PubMed ID: 21609685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro sulfoxidation of thioether compounds by human cytochrome P450 and flavin-containing monooxygenase isoforms with particular reference to the CYP2C subfamily.
    Usmani KA; Karoly ED; Hodgson E; Rose RL
    Drug Metab Dispos; 2004 Mar; 32(3):333-9. PubMed ID: 14977868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.